Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Gvoke Pfs 1-Pack Syringe(Glucagon)Xeris Biopharma Holdings, Inc. logoXERS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Xeris Biopharma Holdings, Inc.

$3.0M

Medicare cost, 2024

Medicare drug plans spent $3.0 million on Gvoke Pfs 1-Pack Syringe (glucagon) in 2024, for 7,084 prescriptions and refills filled by 4,599 patients. Pennsylvania accounts for the most spending ($240,883, 8% of the total). It is made by Xeris Biopharma Holdings, Inc. (XERS).

Medicare cost, 2024

$3.0M

-5.0% from 2023

Prescriptions

7,084

$416.52 per claim

Patients

4,599

3,225 prescribers

Total spending, 2024

$3.0M

$641.44 per patient

Questions and answers

How much does Medicare spend on Gvoke Pfs 1-Pack Syringe?

Medicare prescription drug plans paid $3.0M for Gvoke Pfs 1-Pack Syringe in 2024, for 7,084 prescriptions and refills to 4,599 patients (down 5.0% from 2023). The average cost per claim was $416.52.

Which state spends the most on Gvoke Pfs 1-Pack Syringe?

Pennsylvania had the highest Medicare cost for Gvoke Pfs 1-Pack Syringe in 2024: $241K for 554 claims, followed by New York ($205K).

Who prescribes Gvoke Pfs 1-Pack Syringe the most?

Leah M Weidner, nurse practitioner in Mahanoy City, PA, had the highest Medicare cost for Gvoke Pfs 1-Pack Syringe in 2024: 32 claims costing $19K.

Who makes Gvoke Pfs 1-Pack Syringe?

Gvoke Pfs 1-Pack Syringe is made by Xeris Biopharma Holdings, Inc. (XERS), listed in the Medicare spending data as Xeris Pharmaceu.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Gvoke Pfs 1-Pack Syringe was $3.0M in 2024, after a high of $3.2M in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Gvoke Pfs 1-Pack Syringe, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Leah M Weidner Mahanoy City, PANurse Practitioner32Under 11$19K
Scott J Steven Cherry Hill, NJEndocrinology5439$18K
Mehdi Poorkay Louisville, KYInternal Medicine21Under 11$17K
Matvey Brokhin Brooklyn, NYEndocrinology45Under 11$15K
Michael T Peacock Eastman, GAInternal Medicine4516$15K
Deepa Aravind Smithtown, NYEndocrinology2212$13K
Kristin J Emert Nashville, TNNurse Practitioner2611$13K
Benito Lopez Edinburg, TXPhysician Assistant21Under 11$12K
Laeeq A Tahirkheli Plattsburg, MOInternal Medicine19Under 11$12K
Troy J Ostrander Belden, MSEmergency Medicine3316$12K
Dany H Zayour Wichita, KSInternal Medicine21Under 11$11K
Laura Emmons Philadelphia, PANurse Practitioner1613$11K
Andrew E Graf Plymouth Meeting, PAInternal Medicine33Under 11$11K
Ross B del Fierro Mobile, ALEndocrinology12Under 11$9,691
Chase D Hendrickson Nashville, TNEndocrinology1511$9,305
Martha M Cavazos Ashland, OREndocrinology20Under 11$9,237
Coleen S Acevedo West Reading, PANurse Practitioner23Under 11$8,542
J. G Evans Jacksonville, FLEndocrinology1512$8,506
Adelaide F Henderson Flowood, MSFamily Practice25Under 11$8,383
Russell K Won Saint Louis, MOGeneral Practice22Under 11$8,350
Esther Wei New York, NYNurse Practitioner16Under 11$7,587
Erin E Beauchamp Allegan, MINurse Practitioner21Under 11$7,553
Lisa G Blesse Ellisville, MSNurse Practitioner20Under 11$7,384
Eugenio Angueira-Serrano Miami, FLEndocrinology19Under 11$7,093
Paris Roach Indianapolis, INEndocrinology1714$7,077

Prescriber data by year

YearPrescribersClaimsPatientsCost
20223,3057,2924,678$3.2M
20233,2286,9604,598$3.1M
20243,2257,0844,599$3.0M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Xeris PharmaceuXERS logoXERS7,086$3.0M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube